Nasal saline as a placebo in a rhinosinusitis study

Ahmet Karadag,¹ Ferhat Catal<sup>2

1</sup>Division of Neonatology, ²Division of Pediatric Allergy Department of Pediatrics, School of Medicine, Inonu University, Malatya, Turkey

I read with interest Mainz et al’s article in the February issue of your journal.¹ The authors concluded that sinonasal inhalation of vibrating antibiotic aerosols appears promising for reducing pathogen colonization of paranasal sinuses and for control of symptoms in patients with cystic fibrosis. We have an objection to their study methods.

View original paper by Mainz and colleagues.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.